Medication-Assisted Treatment (MAT)
We are pleased to announce an entirely new ECHO session that will focus on providing support to providers who are currently Medication Assisted Treatment (MAT) certified or are interested in becoming MAT certified. We understand the gap that exists between obtaining MAT certification and actually beginning to prescribe different Medication-Assisted Treatments to patients. We have assembled the very best multidisciplinary team of MAT providers available to us to help you navigate that process and serve as a resource for you as you gain the confidence and experience you will need to become an MAT prescriber.
What is MAT?
Medication assisted treatment (MAT) integrates behavioral health and social services interventions with treatment using an FDA-approved medication for opioid addiction. There are three medications used in MAT: buprenorphine, naltrexone, and methadone. All have been shown to reduce cravings, illicit opioid use, and overdoses. Patients receiving medications as part of their opioid addiction treatment are 75% less likely to die because of their addiction than those not receiving medications. Integrating opioid addiction treatment into your practice as a provider is one way you can personally make a tremendous impact on our state’s opioid epidemic.
While methadone may only be given in designated addiction treatment centers overseen by trained addiction physicians, both buprenorphine and naltrexone can be prescribed by providers of any medical specialty, and in a diverse range of treatment settings. In order to prescribe buprenorphine products, providers are required to obtain a waiver from the DEA and be issued a unique DEA “X” registration number which they can receive after completing an 8 hour training course on MAT for opioid dependency for physicians, and 24 hours for PAs and Nurse Practitioners. To get your DATA waiver training, please click https://pcssnow.org/calendar-of-events/ and follow the PCSS calendar to schedule your training.